Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
A nurse is caring for a client who is experiencing manifestations of opiate withdrawal. Which of the following medications should the nurse anticipate the provider to prescriber
A. Diphenhydramine
Diphenhydramine is an antihistamine and is not typically used to manage opiate withdrawal. It may help with certain symptoms like insomnia or mild anxiety but is not a primary treatment for opioid withdrawal.
B. Methadone
Methadone is commonly used in the treatment of opioid withdrawal. It is a long-acting opioid agonist that helps manage withdrawal symptoms and cravings, providing a more controlled tapering process. Methadone is often used in medication-assisted treatment (MAT) for opioid use disorder.
C. Benzodiazepines
Benzodiazepines are not typically used as the first-line treatment for opioid withdrawal. They may be considered in specific situations, such as when there is severe anxiety or agitation, but they are generally not the primary choice due to the risk of dependence.
D. Naloxone
Naloxone is an opioid antagonist used to reverse opioid overdose. It is not used in the routine management of opioid withdrawal but rather in emergency situations where opioid overdose is suspected.
This question is an excerpt from Nurse Dive's nursing test bank - LPN Custom Mental Health Proctored Exam. Take the full exam now
Full Explanation
A. Diphenhydramine is an antihistamine and is not typically used to manage opiate withdrawal. It may help with certain symptoms like insomnia or mild anxiety but is not a primary treatment for opioid withdrawal.
B. Methadone is commonly used in the treatment of opioid withdrawal. It is a long-acting opioid agonist that helps manage withdrawal symptoms and cravings, providing a more controlled tapering process. Methadone is often used in medication-assisted treatment (MAT) for opioid use disorder.
C. Benzodiazepines are not typically used as the first-line treatment for opioid withdrawal. They may be considered in specific situations, such as when there is severe anxiety or agitation, but they are generally not the primary choice due to the risk of dependence.
D. Naloxone is an opioid antagonist used to reverse opioid overdose. It is not used in the routine management of opioid withdrawal but rather in emergency situations where opioid overdose is suspected.
Similar Questions
A nurse is caring for a client who is prescribed alprazolam, a benzodiazepine for managing severe manifestations of anxiety. Which of the following should the nurse prepare to discuss with the client?
A. Foods that are known to be high in dietary tyramine should be avoided
Foods that are high in dietary tyramine are more relevant to certain antidepressant medications, particularly monoamine oxidase inhibitors (MAOIs), and are not a specific concern with alprazolam.
B. increase the dose of medication as needed if relief of manifestations is not experienced.
Increasing the dose of the medication without consulting the healthcare provider is not appropriate. Adjustments to the dosage should be done under the guidance of the healthcare provider.
C. Avoid driving or eating heavy machinery until you know how alprazolam affects you
Avoid driving or operating heavy machinery until you know how alprazolam affects you.This is an important safety consideration when using benzodiazepines such as alprazolam. Benzodiazepines can cause drowsiness and impair coordination, so clients should be advised to avoid activities that require mental alertness, such as driving or operating machinery, until they are aware of how the medication affects them.
D. manifestations should be expected after a few weeks of therapy.
Manifestations of anxiety should improve with the use of alprazolam, and relief of symptoms can occur relatively quickly. However, it is essential to inform the client that long-term use of benzodiazepines may lead to tolerance and dependence. They should not abruptly stop the medication without consulting their healthcare provider.
Full Explanation
A. Foods that are high in dietary tyramine are more relevant to certain antidepressant medications, particularly monoamine oxidase inhibitors (MAOIs), and are not a specific concern with alprazolam.
B. Increasing the dose of the medication without consulting the healthcare provider is not appropriate. Adjustments to the dosage should be done under the guidance of the healthcare provider.
C. Avoid driving or operating heavy machinery until you know how alprazolam affects you.
This is an important safety consideration when using benzodiazepines such as alprazolam. Benzodiazepines can cause drowsiness and impair coordination, so clients should be advised to avoid activities that require mental alertness, such as driving or operating machinery, until they are aware of how the medication affects them.
D. Manifestations of anxiety should improve with the use of alprazolam, and relief of symptoms can occur relatively quickly. However, it is essential to inform the client that long-term use of benzodiazepines may lead to tolerance and dependence. They should not abruptly stop the medication without consulting their healthcare provider.
A nurse is reinforcing teaching with a client about manifestations of lithium toxicity. Which of the following manifestations should the nurse include in the teaching?
A. Loss of appetite
Loss of appetite is not a specific manifestation of lithium toxicity. However, gastrointestinal symptoms like nausea and vomiting can contribute to a decreased appetite.
B. vomiting and diarrhea
Vomiting and diarrhea.Lithium is a mood stabilizer commonly used in the treatment of bipolar disorder. Toxicity can occur, and symptoms can range from mild to severe. Vomiting and diarrhea are common early signs of lithium toxicity. As toxicity progresses, it can lead to more severe symptoms, such as tremors, confusion, and potentially life-threatening complications.
C. increased flatulence
Increased flatulence is not a typical manifestation of lithium toxicity. Gastrointestinal symptoms associated with lithium toxicity are more likely to include nausea, vomiting, and diarrhea.
D. Increased urination
Increased urination is not a typical manifestation of lithium toxicity. Lithium can affect renal function, leading to decreased urine output, but it does not typically cause increased urination as a sign of toxicity.
Full Explanation
A. Loss of appetite is not a specific manifestation of lithium toxicity. However, gastrointestinal symptoms like nausea and vomiting can contribute to a decreased appetite.
B. Vomiting and diarrhea.
Lithium is a mood stabilizer commonly used in the treatment of bipolar disorder. Toxicity can occur, and symptoms can range from mild to severe. Vomiting and diarrhea are common early signs of lithium toxicity. As toxicity progresses, it can lead to more severe symptoms, such as tremors, confusion, and potentially life-threatening complications.
C. Increased flatulence is not a typical manifestation of lithium toxicity. Gastrointestinal symptoms associated with lithium toxicity are more likely to include nausea, vomiting, and diarrhea.
D. Increased urination is not a typical manifestation of lithium toxicity. Lithium can affect renal function, leading to decreased urine output, but it does not typically cause increased urination as a sign of toxicity.
A nurse is collecting data from a group of clients who have anxiety disorders and have prescriptions for various psychotropic medications. The nurse should recognize which of the following clients as having an increased risk for suicide?
A. A client who has generalized anxiety disorder and takes diazepam (Valium)
Diazepam (Valium) is a benzodiazepine used for anxiety. While benzodiazepines can cause sedation and might carry a risk of dependence, they are not typically associated with an increased risk of suicidal ideation compared to antidepressants.
B. A client who has generalized anxiety disorder and takes diphenhydramine (Benadryl)
Diphenhydramine (Benadryl) is an antihistamine that might cause drowsiness and sedation. It's not primarily used for anxiety disorders, and it's less associated with increased suicidal risk compared to antidepressants.
C. A client who has social anxiety disorder and takes propranolol (inderal)
Propranolol (Inderal) is a beta-blocker used for treating conditions like hypertension and anxiety disorders. It's not typically associated with an increased risk of suicide compared to antidepressants.
D. A client who has an obsessive-compulsive disorder and takes fluoxetine (Prozac
A client who has obsessive-compulsive disorder and takes fluoxetine (Prozac). Fluoxetine (Prozac) is an antidepressant that belongs to the class of medications called selective serotonin reuptake inhibitors (SSRIs). While it's effective for treating OCD, when initiating or adjusting the dosage of an antidepressant like fluoxetine, there can be an increased risk of suicidal ideation or behavior, especially in younger individuals. This risk is particularly prevalent in the initial weeks of treatment or when there are dosage changes.
Full Explanation
A. Diazepam (Valium) is a benzodiazepine used for anxiety. While benzodiazepines can cause sedation and might carry a risk of dependence, they are not typically associated with an increased risk of suicidal ideation compared to antidepressants.
B. Diphenhydramine (Benadryl) is an antihistamine that might cause drowsiness and sedation. It's not primarily used for anxiety disorders, and it's less associated with increased suicidal risk compared to antidepressants.
C. Propranolol (Inderal) is a beta-blocker used for treating conditions like hypertension and anxiety disorders. It's not typically associated with an increased risk of suicide compared to antidepressants.
D. A client who has obsessive-compulsive disorder and takes fluoxetine (Prozac).
Fluoxetine (Prozac) is an antidepressant that belongs to the class of medications called selective serotonin reuptake inhibitors (SSRIs). While it's effective for treating OCD, when initiating or adjusting the dosage of an antidepressant like fluoxetine, there can be an increased risk of suicidal ideation or behavior, especially in younger individuals. This risk is particularly prevalent in the initial weeks of treatment or when there are dosage changes.